CYBA Gene Granulomatous disease chronic autosomal recessive cytochrome b-negative Genetic Test sale cost 4400 AED
COL9A3 Gene Epiphyseal dysplasia multiple type 3 Genetic Test sale cost 4400 AED COL9A3 Gene Epiphyseal dysplasia multiple type 3 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
SLC29A3 Gene Histiocytosis-lymphadenopathy plus syndrome Genetic Test sale cost 4400 AED SLC29A3 Gene Histiocytosis-lymphadenopathy plus syndrome Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

CYBA Gene Granulomatous disease chronic autosomal recessive cytochrome b-negative Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “CYBA Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome b-Negative Genetic Test” is a specialized diagnostic examination designed to identify mutations in the CYBA gene. This gene plays a critical role in the proper functioning of the immune system, specifically in the production of cytochrome b-558, a component essential for the respiratory burst in phagocytes. Mutations in the CYBA gene can lead to a form of Chronic Granulomatous Disease (CGD), an autosomal recessive condition characterized by the immune system’s inability to effectively combat certain bacteria and fungi, leading to repeated infections and the formation of granulomas.

This genetic test is crucial for the early detection and management of CGD, enabling healthcare providers to tailor treatments that can significantly improve the quality of life for affected individuals. The test involves analyzing the patient’s DNA to look for abnormalities in the CYBA gene that would confirm the diagnosis of CGD.

Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test provides a comprehensive analysis with high accuracy. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to perform this detailed genetic analysis. Early diagnosis through this test can lead to better management of the disease, potentially preventing severe infections and other complications associated with CGD.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CYBA Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome b-Negative Genetic Test

Welcome to DNA Labs UAE, where we offer the CYBA Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome b-Negative Genetic Test.

Test Details

The CYBA gene is associated with a condition called granulomatous disease, a chronic disorder characterized by the formation of granulomas (inflammatory nodules) in various organs of the body. This condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene (one from each parent) to develop the disease.

The term “cytochrome b-negative” refers to a specific type of granulomatous disease caused by mutations in the CYBA gene. The CYBA gene provides instructions for producing a protein called cytochrome b-245, which is an essential component of an enzyme complex involved in the immune system’s defense against infections. Mutations in the CYBA gene lead to a deficiency or absence of cytochrome b-245, impairing the immune system’s ability to fight off certain infections.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Osteology Dermatology Immunology Disorders

Referring Doctor and Test Department

This test is recommended by dermatologists and falls under the Genetics department.

Pre Test Information

Prior to undergoing the CYBA Gene Granulomatous Disease Chronic Autosomal Recessive Cytochrome b-Negative Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with the CYBA Gene Granulomatous Disease.

NGS Technology

Next-Generation Sequencing (NGS) is a genetic testing technique that allows for the simultaneous analysis of multiple genes, including the CYBA gene. NGS can identify mutations or variants in the CYBA gene that may be responsible for the granulomatous disease in an affected individual. This type of genetic testing can help with diagnosis, prognosis, and potentially guide treatment decisions for individuals with granulomatous disease.

Thank you for considering DNA Labs UAE for your genetic testing needs. If you have any further questions or would like to schedule an appointment, please contact us.

Test Name CYBA Gene Granulomatous disease chronic autosomal recessive cytochrome b-negative Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CYBA Gene Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CYBA Gene Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative NGS Genetic DNA Test gene CYBA
Test Details

The CYBA gene is associated with a condition called granulomatous disease, which is a chronic disorder characterized by the formation of granulomas (inflammatory nodules) in various organs of the body. This condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene (one from each parent) to develop the disease.

The term “cytochrome b-negative” refers to a specific type of granulomatous disease caused by mutations in the CYBA gene. The CYBA gene provides instructions for producing a protein called cytochrome b-245, which is an essential component of an enzyme complex involved in the immune system’s defense against infections. Mutations in the CYBA gene lead to a deficiency or absence of cytochrome b-245, impairing the immune system’s ability to fight off certain infections.

NGS (Next-Generation Sequencing) is a genetic testing technique that allows for the simultaneous analysis of multiple genes, including the CYBA gene. NGS can identify mutations or variants in the CYBA gene that may be responsible for the granulomatous disease in an affected individual. This type of genetic testing can help with diagnosis, prognosis, and potentially guide treatment decisions for individuals with granulomatous disease.

SKU: TEST-3004 Category:

Related products